• Profile
Close

Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma

BMC Cancer Jun 09, 2019

Yang Y, et al. - Among 416 esophageal squamous cell carcinoma (ESCC) patients, researchers used Kaplan-Meier method with log-rank test, followed by multivariate Cox regression models, to determine the link between tumor markers [cytokeratin 19 fragment antigen 21–1, carbohydrate antigen 19–9 (CA19–9), carbohydrate antigen 72–4, carcinoembryonic antigen (CEA) and squamous cell carcinoma antigen (SCC-Ag)] and overall survival (OS). CA19–9 (≥ 37 vs < 37) and CEA (≥ 5 vs < 5) were identified as the independent prognostic factors of poor OS in Cox multivariate analysis. In ESCC, possible superiority of CEA and CA19–9 as prognostic indicators was suggested in comparison to other tumor biomarkers. As a predictor of the therapeutic impact of postoperative chemotherapy in ESCC, a possible utility of CA19–9, CEA, and SCC-Ag was indicated.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay